Lotus Pharmaceuticals, Inc. (``Lotus'') controls and operates Liang Fang Pharmaceutical, Ltd. (``Liang'') and En Zhe Jia Shi Pharmaceutical, Ltd. (``En Zhe''), two Chinese pharmaceutical companies located in Beijing. Liang and En Zhe form a large comprehensive enterprise, which deals in an integration of the production, trade, sales and marketing of pharmaceuticals. Together, they possess some of the most advanced pharmaceutical-production equipment used in China, workshops authenticated by the National GMP, a suite of various medicines produced by Liang and/or En Zhe (together, ``Lotus East''), and a number of high-tech personnel. Lotus East has business and office facilities of 2,000 square meters, warehouse of 1,000 square meters and operates ten retail pharmacies in the Beijing area. Lotus East performs scientific research on new medicines, and the production, wholesale and retail sale of medicines. For more information, visit http://www.LotusEast.com.

Contact Information

7900 Glades Road
Suite 420
Boca Raton, FL 33434

tel: 954-208-0154
fax: 561-988-9890


Investor Relations



Exchange: OTCBB
Industry: Drugs - Generic
Market Cap: $24.9M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.